Insights on Investing in CL from Our Analysts

By Tamara Parker • Friday, January 31 10:14 • Permanent Link

Large-cap Consumer Discretionary company Colgate-Palmolive has moved -5.0% so far today on a volume of 2,558,218, compared to its average of 4,630,149. In contrast, the S&P 500 index moved 1.0%.

Colgate-Palmolive trades -14.38% away from its average analyst target price of $100.87 per share. The 22 analysts following the stock have set target prices ranging from $83.0 to $120.0, and on average have given Colgate-Palmolive a rating of buy.

Anyone interested in buying CL should be aware of the facts below:

Colgate-Palmolive's current price is 1175.7% above its Graham number of $6.77, which implies that at its current valuation it does not offer a margin of safety
Colgate-Palmolive has moved 5.8% over the last year, and the S&P 500 logged a change of 21.8%
Based on its trailing earnings per share of 3.48, Colgate-Palmolive has a trailing 12 month Price to Earnings (P/E) ratio of 24.8 while the S&P 500 average is 29.3
CL has a forward P/E ratio of 22.4 based on its forward 12 month price to earnings (EPS) of $3.86 per share
Its Price to Book (P/B) ratio is 162.34 compared to its sector average of 3.19
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally.
Based in New York, the company has 34,000 full time employees and a market cap of $70.56 Billion. Colgate-Palmolive currently returns an annual dividend yield of 2.2%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.